Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activity.
Boulton DP, Hughes CJ, Vaira V, Del Gobbo A, Palleschi A, Locatelli M, Danis E, Raza M, Neumann AJ, Purdy SC, Lerma R, Meshki J, Ford HL, Prekeris R, Morrissey C, Caino MC. Boulton DP, et al. Among authors: del gobbo a. Cell Rep. 2024 Dec 24;44(1):115120. doi: 10.1016/j.celrep.2024.115120. Online ahead of print. Cell Rep. 2024. PMID: 39723893 Free article.
Digital transition in pathology lab: a survey from the Lombardy region.
Belloni E, Bonoldi E, Bovo G, Buoro S, Cerati M, Cribiú FM, Dainese E, Del Gobbo A, Facchetti M, Gianatti A, Gianelli U, Giunta P, L'Imperio V, Milione M, Nebuloni M, Pagni F, Paulli M, Piga A, Pasotti F. Belloni E, et al. Among authors: del gobbo a. Pathologica. 2024 Aug;116(4):232-241. doi: 10.32074/1591-951X-1004. Pathologica. 2024. PMID: 39377505 Free PMC article.
Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept.
Favi E, Cresseri D, Perego M, Ikehata M, Iesari S, Campise MR, Morello W, Testa S, Sioli V, Mattinzoli D, Longhi E, Del Gobbo A, Castellano G, Ferraresso M. Favi E, et al. Among authors: del gobbo a. Clin Immunol. 2024 Jul;264:110240. doi: 10.1016/j.clim.2024.110240. Epub 2024 May 9. Clin Immunol. 2024. PMID: 38734036 Free article.
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.
Simbolo M, Centonze G, Gkountakos A, Monti V, Maisonneuve P, Golovco S, Sabella G, Del Gobbo A, Gobbo S, Ferrero S, Fabbri A, Pardo C, Garzone G, Prinzi N, Pusceddu S, Testi A, Rolli L, Mangogna A, Bercich L, Benvenuti MR, Bria E, Pilotto S, Berruti A, Pastorino U, Capella C, Infante M, Milella M, Scarpa A, Milione M. Simbolo M, et al. Among authors: del gobbo a. Virchows Arch. 2024 May;484(5):777-788. doi: 10.1007/s00428-023-03721-4. Epub 2024 Jan 3. Virchows Arch. 2024. PMID: 38168015 Free PMC article.
Clinical Data Do Not Reliably Predict Duodenal Histology at Follow-up in Celiac Disease: A 13 Center Correlative Study.
Patel N, Leffler DA, Al-Toma A, Mulder CJ, Elli L, Gan G, Patil P, Atsawarungruangkit A, Kuijpers KC, Del Gobbo A, Goldsmith J, Hintze Z, Pacheco MC, Vieth M, Melcher B, Salomao M, Pai R, Hart J, Olivas A, Naini B, Meyerson C, Choi WT, Kakar S, Westerhoff M, Cheng J, Gopal P, Hammer S, Moreno Prats M, Bronner MP, Robert ME. Patel N, et al. Among authors: del gobbo a. Am J Surg Pathol. 2024 Feb 1;48(2):212-220. doi: 10.1097/PAS.0000000000002150. Epub 2023 Nov 23. Am J Surg Pathol. 2024. PMID: 37994653
Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies.
Mendogni P, Affatato R, Cabri E, Chiappa M, Ndembe G, Tosi D, Del Gobbo A, Fratelli M, Pardini E, Petrini I, Rosso L, Broggini M, Marabese M. Mendogni P, et al. Among authors: del gobbo a. J Exp Clin Cancer Res. 2022 Dec 14;41(1):343. doi: 10.1186/s13046-022-02554-4. J Exp Clin Cancer Res. 2022. PMID: 36517829 Free PMC article.
73 results